Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,850 | -36,390 | -29,390 | -19,390 | -14,280 |
| Depreciation Amortization | 120 | 100 | 90 | 60 | 210 |
| Other Working Capital | -1,330 | 1,180 | 3,830 | -1,660 | -530 |
| Other Operating Activity | 320 | 840 | 2,660 | 3,480 | 460 |
| Operating Cash Flow | $-23,740 | $-34,270 | $-22,810 | $-17,510 | $-14,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -240 | -120 | -260 | -70 | -8 |
| Other Investing Activity | -30 | -30 | 1,690 | -1,930 | 3,658 |
| Investing Cash Flow | $-270 | $-150 | $1,430 | $-2,000 | $3,650 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 29,520 | 20,860 | 15,000 | 26,490 | 32,610 |
| Financing Cash Flow | $29,520 | $20,860 | $15,000 | $26,490 | $32,610 |
| Exchange Rate Effect | 220 | -30 | -70 | -330 | -110 |
| Beginning Cash Position | 18,770 | 32,930 | 39,760 | 31,500 | 6,540 |
| End Cash Position | 24,490 | 19,330 | 33,310 | 38,150 | 28,560 |
| Net Cash Flow | $5,720 | $-13,600 | $-6,450 | $6,640 | $22,020 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,740 | -34,270 | -22,810 | -17,510 | -14,140 |
| Free Cash Flow | -23,740 | -34,270 | -22,810 | -17,510 | -14,140 |